{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:36:09Z","timestamp":1772253369504,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00839205","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T10:36:33Z","timestamp":1103538993000},"page":"16-20","source":"Crossref","is-referenced-by-count":141,"title":["Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use"],"prefix":"10.1007","volume":"239","author":[{"given":"Peter","family":"Hambleton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-12-447180-1.50032-8","volume-title":"Biomedical aspects of botulism","author":"S Arnon","year":"1981","unstructured":"Arnon S (1981) Infant botulism, pathogenesis, clinical aspects and relation to crib death. In: Lewis GE Jr (ed) Biomedical aspects of botulism. Academic Press, New York, pp 331?345"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.103.2.521","volume":"103","author":"JD Black","year":"1986","unstructured":"Black JD, Dolly JO (1986) Interaction of125I-labelled botulinum neurotoxins with nerve terminals. J Cell Biol 103:521?534","journal-title":"J Cell Biol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0006-291X(72)90350-6","volume":"48","author":"BR Gupta Das","year":"1972","unstructured":"Das Gupta BR, Sugiyama H (1972) A common subunit structure inClostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun 48:108?112","journal-title":"Biochem Biophys Res Commun"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0041-0101(82)90183-0","volume":"20","author":"JO Dolly","year":"1982","unstructured":"Dolly JO, Williams RS, Black JD, Tse CK, Hambleton P, Melling J (1982) Localisation of sites for 125-I labelled neurotoxin at the murine neuromuscular junction and its binding to rat brain synaptosomes. Toxicon 20:141?148","journal-title":"Toxicon"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","volume":"307","author":"JO Dolly","year":"1984","unstructured":"Dolly JO, Black JD, Williams RS, Melling J (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation. Nature 307:457?460","journal-title":"Nature"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/j.1460-2075.1986.tb04527.x","volume":"5","author":"J Eisel","year":"1986","unstructured":"Eisel J, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U, Hudel M, Hambermann E, Neimann H (1986) Tetanus toxin: primary structure expression inE. coli and homology with botulinum toxins. EMBO J 5:2495?2502","journal-title":"EMBO J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1093\/nar\/14.19.7809","volume":"14","author":"NF Fairweather","year":"1986","unstructured":"Fairweather NF, Lyness VA (1986) The complete neucleotide sequence of tetanus toxin. Nucleic Acids Res 14:7809?7812","journal-title":"Nucleic Acids Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-12-447180-1.50026-2","volume-title":"Biomedical aspects of botulism","author":"RA Feldman","year":"1981","unstructured":"Feldman RA, Morris JG, Pollard RA (1981) Epidemiological characteristics of botulism in the United States. In: Lewis GE Jr (ed) Biomedical aspects of botulism. Academic Press, New York, pp 271?284"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9394(88)90016-5","volume":"105","author":"RS Gonnering","year":"1988","unstructured":"Gonnering RS (1988) Negative antibody response to long-term treatments of facial spasm with botulinum toxin. Am J Ophthalmol 105:313?315","journal-title":"Am J Ophthalmol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/B978-0-12-447180-1.50024-9","volume-title":"Biomedical aspects of botulism","author":"P Hambleton","year":"1981","unstructured":"Hambleton P, Capel B, Bailey N, Heron N, Crooks A, Melling J (1981) Production, purification and toxoiding ofClostridium botulinum type A toxin. In: Lewis GE Jr (ed) Biomedical aspects of botulism. Academic Press, New York, pp 247?260"},{"key":"CR11","first-page":"233","volume-title":"Neurotoxins and their parmacological implications","author":"P Hambleton","year":"1987","unstructured":"Hambleton P, Shone CC, Melling J (1987) Botulinum toxinstructure, action and clinical uses. In: Jenner P (ed) Neurotoxins and their parmacological implications. Raven Press, New York, pp 233?260"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00499721","volume":"308","author":"S Kozaki","year":"1979","unstructured":"Kozaki S (1979) Interaction of type A, B and E derivative toxins with synaptosomes of rat brain. Naunyn Schmiedeberg's Arch Pharmacol 308:67?70","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"CR13","first-page":"11\/1","volume-title":"Essays in applied microbiology","author":"J Melling","year":"1981","unstructured":"Melling J, Allner K (1981) The containment of microorganisms. In: Norris JR, Richmond MH (eds) Essays in applied microbiology. Wiley, New York, pp 11\/1?11\/32"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/eye.1988.5","volume":"2","author":"J Melling","year":"1988","unstructured":"Melling J, Hambleton P, Shone CC (1988)Clostridium botulinum toxins: nature and preparation for clinical use. Eye 2:16?23","journal-title":"Eye"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(84)90572-9","volume":"279","author":"J Molgo","year":"1984","unstructured":"Molgo J, Thesleff S (1984) Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction. Brain Res 279:309?316","journal-title":"Brain Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1432-1033.1984.tb08312.x","volume":"142","author":"S Murayama","year":"1984","unstructured":"Murayama S, Syoto B, Oguma K, Iida H, Kubo S (1984) Comparison ofClostridium botulinum toxin types D and C1 in molecular property antigenicity and binding ability to rat brain synaptosomes. Eur J Biochem 142:487?492","journal-title":"Eur J Biochem"},{"key":"CR17","first-page":"493","volume":"49","author":"JR Patrinely","year":"1988","unstructured":"Patrinely JR, Whiting AS, Anderson RL (1988) Local side effects of botulinum toxin infections. Adv Neurol 49:493?500","journal-title":"Adv Neurol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1432-1033.1989.tb15102.x","volume":"185","author":"B Poulain","year":"1989","unstructured":"Poulain B, Wadsworth JDF, Maisey EA, Shone CC, Melling J, Tauc L, Dolly JO (1989) Inhibition of transmitter release by botulinum toxin A. Contribution of various fragments to the intoxication process. Eur J Biochem 185:197?203","journal-title":"Eur J Biochem"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"21928","DOI":"10.1016\/S0021-9258(20)88274-X","volume":"264","author":"B Poulain","year":"1989","unstructured":"Poulain B, Wadsworth JDF, Shone CC, Mochida S, Lande S, Melling J, Dolly JO, Taue L (1989) Multiple domains of botulinum neurotoxin contribute to its inhibiton of neurotransmitter release. J Biol Chem 264:21928?21933","journal-title":"J Biol Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(89)92551-8","volume":"I","author":"N Quinn","year":"1989","unstructured":"Quinn N, Hallett M (1989) Dose standardisation of botulinum toxin. Lancet I:964","journal-title":"Lancet"},{"key":"CR21","first-page":"408","volume":"I","author":"Report of Working Party on Leukaemia in Childhood","year":"1986","unstructured":"Report of Working Party on Leukaemia in Childhood (1986) Improvement for children with acute lymphoblastic leukaemia. Lancet I:408","journal-title":"Lancet"},{"key":"CR22","first-page":"433","volume-title":"Bacterial protein toxins","author":"G Sakaguchi","year":"1984","unstructured":"Sakaguchi G, Kozaki S, Ohishi I (1984) Structure and function of botulinum toxins. In: Alouf JE, Fehrenbach FJ, Freer JG, Jeljiaszewicz J (eds) Bacterial protein toxins. Academic Press, London, pp 433?443"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1432-1033.1987.tb11494.x","volume":"165","author":"J Sanchez-Prieto","year":"1987","unstructured":"Sanchez-Prieto J, Shira TS, Evans D, Ashton A, Dolly JO, Nicholls DG (1987) Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes. Eur J Biochem 165:675?681","journal-title":"Eur J Biochem"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B978-0-12-644445-2.50026-X","volume-title":"Botulinum neurotoxin and tetanus toxin","author":"AB Scott","year":"1989","unstructured":"Scott AB (1989) Clostridial toxins as therapeutic agents. In: Simpson LL (ed) Botulinum neurotoxin and tetanus toxin. Academic Press, New York, pp 399?412"},{"key":"CR25","first-page":"924","volume":"12","author":"AB Scott","year":"1973","unstructured":"Scott AB, Rosenbaum AL, Collins CC (1973) Pharmacological weakening of extraocular muscles. Invest Ophthalmol 12:924?927","journal-title":"Invest Ophthalmol"},{"key":"CR26","first-page":"11","volume-title":"Natural toxicants in foods","author":"CC Shone","year":"1987","unstructured":"Shone CC (1987) Clostridium botulinum neurotoxins, their structures and modes of action. In: Watson Ellis D (ed) Natural toxicants in foods. Horwood, Chichester, pp 11?57"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4757-9718-3_8","volume-title":"Clostridia","author":"CC Shone","year":"1989","unstructured":"Shone CC, Hambleton P (1989) Toxigenic clostridia. In: Minton NP, Clarke DJ (eds)Clostridia. Plenum Press, New York, pp 265?292"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1432-1033.1985.tb09070.x","volume":"151","author":"CC Shone","year":"1985","unstructured":"Shone CC, Hambleton P, Melling J (1985) Inactivation ofClostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Eur J Biochem 151:75?85","journal-title":"Eur J Biochem"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1432-1033.1987.tb13320.x","volume":"167","author":"CC Shone","year":"1987","unstructured":"Shone CC, Hambleton P, Melling J (1987) A 50 kDa fragment from the NH2 terminus of the heavy subuinite ofClostridium botulinum type A neurotoxin forms channels in lipid vesides. Eur J Biochem 167:175?180","journal-title":"Eur J Biochem"},{"key":"CR30","first-page":"155","volume":"33","author":"LL Simpson","year":"1981","unstructured":"Simpson LL (1981) The origin, structural and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155?188","journal-title":"Pharmacol Rev"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-1033.1990.tb15461.x","volume":"189","author":"DE Thompson","year":"1990","unstructured":"Thompson DE, Brehm JK, Oultram JD, Swinfield T-J, Shone CC, Atkinson T, Melling J, Minton NP (1990) The complete amino acid sequence of theClostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem 189:73?81","journal-title":"Eur J Biochem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00839205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00839205\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00839205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T21:47:30Z","timestamp":1625176050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00839205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00839205"],"URL":"https:\/\/doi.org\/10.1007\/bf00839205","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}